Illumination provides clear imaging for poor red reflex eyes

Article

Intracameral illumination provides high-quality imaging and near 360° lens capsule structure visualization in eyes with poor red reflex, states a recent paper.

Intracameral illumination provides high-quality imaging and near 360° lens capsule structure visualization in eyes with poor red reflex, states a recent paper.

The interventional case series, conducted by a team led by Dr Yun Jung, Department of Ophthalmology, Gachon University Gil Hospital, Incheon, Korea, comprised of 17 eyes of 17 patients. All patients underwent surgeon-controlled intracameral illumination for combined cataract surgery and 23-gauge vitrectomy.

The main outcome measures included causes of the poor red reflex, value of the intracameral illuminator in specific cataract steps and intraoperative and postoperative complications.

Main causes of poor red reflex included vitreous haemorrhage in 8 eyes, vitreous opacity in 6 eyes and corneal opacity, bullous retinal detachment and globe deviation in 1 eye each.

Amount of corneal scatter and reflection of illuminating light was minimized by horizontal or oblique intracameral illumination. The excellent visibility of the lens capsules assisted the removal of almost all lens epithelial cells from the capsular bag.

All eyes underwent complete capsulorhexis and in-the-bag implantation of an IOL. Only one eye presented with a radial anterior capsule tear during irrigation/aspiration. The intracameral illumination procedure can be used for challenging cataract surgery combined with vitrectomy.

For the abstract please visit the Journal of Cataract and Refractive Surgery.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.